A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanoma.

by Patrick A Ott, Anne Hamilton, Amanda Jones, Naomi Haas, Tsiporah Shore, Sandra Liddell, Paul J Christos, L Austin Doyle, Michael Millward, Franco M Muggia, Anna C Pavlick
Published 2010-01-01